[PANAMY] QoQ Annualized Quarter Result on 30-Jun-2015 [#1]

Stock
[PANAMY] PANASONIC MANUFACTURING MSIA
Announcement Date
24-Aug-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2016
Quarter
30-Jun-2015 [#1]
Profit Trend
QoQ- 27.78%
YoY- 37.07%
Quarter Report
Latest QR
Upcoming QR
PANAMY's Result
PANAMY's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Revenue 1,086,735 1,116,006 1,095,744 1,068,828 931,020 1,001,117 999,326 5.74%
PBT 185,172 195,818 184,034 165,020 129,833 130,694 128,322 27.66%
Tax -38,272 -48,232 -39,846 -37,828 -30,295 -29,797 -29,756 18.25%
NP 146,900 147,586 144,188 127,192 99,538 100,897 98,566 30.44%
-
NP to SH 146,900 147,586 144,188 127,192 99,538 100,897 98,566 30.44%
-
Tax Rate 20.67% 24.63% 21.65% 22.92% 23.33% 22.80% 23.19% -
Total Cost 939,835 968,420 951,556 941,636 831,482 900,220 900,760 2.86%
-
Net Worth 779,371 752,035 713,158 750,213 718,625 703,438 677,317 9.79%
Dividend
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Div 84,436 12,149 18,223 - 9,111 12,149 18,223 177.67%
Div Payout % 57.48% 8.23% 12.64% - 9.15% 12.04% 18.49% -
Equity
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Net Worth 779,371 752,035 713,158 750,213 718,625 703,438 677,317 9.79%
NOSH 60,746 60,746 60,746 60,746 60,746 60,746 60,746 0.00%
Ratio Analysis
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
NP Margin 13.52% 13.22% 13.16% 11.90% 10.69% 10.08% 9.86% -
ROE 18.85% 19.62% 20.22% 16.95% 13.85% 14.34% 14.55% -
Per Share
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 1,788.98 1,837.17 1,803.81 1,759.50 1,532.64 1,648.04 1,645.09 5.74%
EPS 242.00 242.67 238.00 208.00 164.00 165.33 162.00 30.64%
DPS 139.00 20.00 30.00 0.00 15.00 20.00 30.00 177.66%
NAPS 12.83 12.38 11.74 12.35 11.83 11.58 11.15 9.79%
Adjusted Per Share Value based on latest NOSH - 60,746
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
RPS 1,788.99 1,837.18 1,803.82 1,759.51 1,532.65 1,648.04 1,645.10 5.74%
EPS 241.83 242.96 237.36 209.38 163.86 166.10 162.26 30.44%
DPS 139.00 20.00 30.00 0.00 15.00 20.00 30.00 177.66%
NAPS 12.83 12.38 11.74 12.35 11.83 11.58 11.15 9.79%
Price Multiplier on Financial Quarter End Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 -
Price 29.68 24.28 20.80 23.00 23.20 18.50 20.00 -
P/RPS 1.66 1.32 1.15 1.31 1.51 1.12 1.22 22.76%
P/EPS 12.27 9.99 8.76 10.98 14.16 11.14 12.33 -0.32%
EY 8.15 10.01 11.41 9.10 7.06 8.98 8.11 0.32%
DY 4.68 0.82 1.44 0.00 0.65 1.08 1.50 113.37%
P/NAPS 2.31 1.96 1.77 1.86 1.96 1.60 1.79 18.51%
Price Multiplier on Announcement Date
31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 CAGR
Date 30/05/16 26/02/16 27/11/15 24/08/15 27/05/15 26/02/15 28/11/14 -
Price 29.70 25.20 22.56 21.42 21.80 21.18 18.30 -
P/RPS 1.66 1.37 1.25 1.22 1.42 1.29 1.11 30.74%
P/EPS 12.28 10.37 9.50 10.23 13.30 12.75 11.28 5.82%
EY 8.14 9.64 10.52 9.78 7.52 7.84 8.87 -5.55%
DY 4.68 0.79 1.33 0.00 0.69 0.94 1.64 101.05%
P/NAPS 2.31 2.04 1.92 1.73 1.84 1.83 1.64 25.62%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment